General

Filter:AllGeneralRegulatory NewsNewsletterExternalManufacturingPress ReleaseSkills and TrainingChallenge Theme – PATChallenge Theme – AAVChallenge Theme – iPSCsNon ClinicalCommercialisation of Research
Year:All2024202320222021 →
Bringing SMEs together with investors to secure funding for the UK industryBringing SMEs together with investors to secure funding for the UK industryiMATCH ATTC given boost for expanding use of cell and gene therapies in the UKiMATCH ATTC given boost for expanding use of cell and gene therapies in the UKCGT Catapult supports translation of research across the UK through engagement with key academic hubsCGT Catapult supports translation of research across the UK through engagement with key academic hubsFlagship EU programme launchedFlagship EU programme launchedPress Release: CGT Catapult Celebrates First Successful Months of Novel Apprenticeship Programme to Secure Future Skills for Advanced TherapiesPress Release: CGT Catapult Celebrates First Successful Months of Novel Apprenticeship Programme to Secure Future Skills for Advanced TherapiesAutolus approved to manufacture clinical trial products at the Cell and Gene Therapy Catapult manufacturing centreAutolus approved to manufacture clinical trial products at the Cell and Gene Therapy Catapult manufacturing centrePress release: Surge in cell and gene therapy trials highlight the UK’s leading position as developmental hub in this innovative industryPress release: Surge in cell and gene therapy trials highlight the UK’s leading position as developmental hub in this innovative industryPress release: CGT Catapult and pHion Therapeutics Announce Licencing Agreement for the RALA TechnologyPress release: CGT Catapult and pHion Therapeutics Announce Licencing Agreement for the RALA TechnologyMidlands - Wales ATTC to lead ground-breaking research into patient experience of cell therapiesMidlands - Wales ATTC to lead ground-breaking research into patient experience of cell therapiesCobra Biologics, Pall Corporation and CGT Catapult Win £1.5M Innovate UK Grant to Investigate Continuous Manufacturing for Gene TherapiesCobra Biologics, Pall Corporation and CGT Catapult Win £1.5M Innovate UK Grant to Investigate Continuous Manufacturing for Gene TherapiesAddressing the Sector Skills Gap with First Apprenticeship Programme for Advanced TherapiesAddressing the Sector Skills Gap with First Apprenticeship Programme for Advanced TherapiesCGT Catapult hosts workshop to tackle key challenges in advanced therapy adoption by the NHSCGT Catapult hosts workshop to tackle key challenges in advanced therapy adoption by the NHS